GlycoMimetics Statistics

Total Valuation

GlycoMimetics has a market cap or net worth of $8.56 million. The enterprise value is $2.95 million.

Market Cap	8.56M
Enterprise Value	2.95M

Important Dates

The last earnings date was Thursday, October 26, 2023, after market close.

Earnings Date	Oct 26, 2023
Ex-Dividend Date	n/a

Share Statistics

GlycoMimetics has 645,320 shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	645,320
Shares Outstanding	645,320
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	2.66%
Owned by Institutions (%)	16.90%
Float	427,820

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.54
P/TBV Ratio	2.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.29

Current Ratio	2.29
Quick Ratio	2.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -182.66% and return on invested capital (ROIC) is -90.35%.

Return on Equity (ROE)	-182.66%
Return on Assets (ROA)	-73.99%
Return on Invested Capital (ROIC)	-90.35%
Return on Capital Employed (ROCE)	-704.92%
Revenue Per Employee	n/a
Profits Per Employee	-$7.37M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.60
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	14,506

Short Selling Information

Short Interest	1.71M
Short Previous Month	1.68M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.79M
Pretax Income	n/a
Net Income	-29.49M
EBITDA	-23.76M
EBIT	-23.79M
Earnings Per Share (EPS)	-$45.72

Full Income Statement

Balance Sheet

The company has $5.61 million in cash and n/a in debt, giving a net cash position of $5.61 million or $8.70 per share.

Cash & Cash Equivalents	5.61M
Total Debt	n/a
Net Cash	5.61M
Net Cash Per Share	$8.70
Equity (Book Value)	3.38M
Book Value Per Share	5.23
Working Capital	3.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.70 million and capital expenditures -$2,533, giving a free cash flow of -$25.70 million.

Operating Cash Flow	-25.70M
Capital Expenditures	-2,533
Free Cash Flow	-25.70M
FCF Per Share	-$39.82

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GlycoMimetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	-0.19%
Earnings Yield	-344.33%
FCF Yield	-300.09%

Dividend Details

Analyst Forecast

The average price target for GlycoMimetics is $22.00, which is 85.85% higher than the current price. The consensus rating is "Buy".

Price Target	$22.00
Price Target Difference	85.85%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 16, 2025. It was a reverse split with a ratio of 0.01:1.

Last Split Date	Jun 16, 2025
Split Type	Reverse
Split Ratio	0.01:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1